The effects of early coronary patency on the evolution of myocardial infarction: a prospective arteriographic study
- PMID: 3314951
- PMCID: PMC1277266
- DOI: 10.1136/hrt.58.4.345
The effects of early coronary patency on the evolution of myocardial infarction: a prospective arteriographic study
Abstract
The effects of early spontaneous coronary patency on the evolution of myocardial infarction were evaluated in 41 patients. They had coronary arteriography (mean (SEM)) 3.1 (0.2) hours after the onset of chest pain with repeat studies 90 minutes and three days later. In 12 (29%) patients the infarct related coronary artery was patent at the first arteriogram (group 1). A further 10 patients, nine of whom received thrombolytic treatment, showed early recanalisation of the infarct related coronary artery within 90 minutes of treatment (group 2). In the remainder the infarct related coronary artery was persistently occluded (group 3). Baseline values for infarct location, the sum of ST elevation in all leads, QRS scores, and serum creatine kinase activity did not permit discrimination between the groups. Nevertheless, patterns of ST segment change and enzyme release in group 1 were closely similar to those that occurred in response to thrombolysis in group 2. Thus compared with group 3, groups 1 and 2 showed earlier 50% reduction in the sum of peak ST elevation in all leads and earlier peaking of serum creatine kinase activity. Importantly, creatine kinase release was significantly attenuated in group 1, rising to a peak serum activity (mean (SEM)) of only 1242 (415) IU/1. Analysis of angiographic left ventricular ejection fractions at three days indicated limitation of infarct size in groups 1 and 2 compared with group 3. Mean (SEM) ejection fraction, however, was best preserved in group 1 (62(6)%) and in this group the frequency of non-Q wave infarction was higher than in groups 2 and 3. Thus in patients who present with a patent infarct related coronary artery early during infarction: (a) there is a reduction in the pattern of infarct size as reflected by attenuation of release of creatine kinase, preservation of left ventricular ejection fraction, and a relatively high frequency of non-Q wave infarction; (b) patterns of ST segment change and creatine kinase release resemble those that occur after successful thrombolytic treatment, suggesting that early coronary patency is the result of spontaneous recanalisation of a previously occluded artery.
Similar articles
-
Non-invasive diagnosis of arterial patency after thrombolytic treatment and its relation to prognosis.Br Heart J. 1993 Jun;69(6):485-91. doi: 10.1136/hrt.69.6.485. Br Heart J. 1993. PMID: 8343313 Free PMC article.
-
Electrocardiographic and enzymatic infarct size in a randomised study of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.Drugs. 1987;33 Suppl 3:198-208. doi: 10.2165/00003495-198700333-00035. Drugs. 1987. PMID: 3315592 Clinical Trial.
-
Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators.Circulation. 1998 Feb 10;97(5):444-50. doi: 10.1161/01.cir.97.5.444. Circulation. 1998. PMID: 9490238 Clinical Trial.
-
Effects on infarct size and left ventricular function of early intravenous injection of anistreplase in acute myocardial infarction. The APSIM Study Investigators.Clin Cardiol. 1990 Mar;Suppl 5:V39-44; discussion V67-72. doi: 10.1002/clc.4960131310. Clin Cardiol. 1990. PMID: 2182240 Review.
-
Use of left ventricular function as an end point of thrombolytic therapy.Am J Cardiol. 1991 Dec 5;68(16):23E-29E. doi: 10.1016/0002-9149(91)90302-2. Am J Cardiol. 1991. PMID: 1746448 Review.
Cited by
-
Early diagnosis of acute myocardial infarction.BMJ. 1990 Oct 27;301(6758):941-2. doi: 10.1136/bmj.301.6758.941. BMJ. 1990. PMID: 2249020 Free PMC article. No abstract available.
-
French multicenter trial of anistreplase versus heparin in acute myocardial infarction.Cardiovasc Drugs Ther. 1990 Oct;4(5):1337-44. doi: 10.1007/BF02018261. Cardiovasc Drugs Ther. 1990. PMID: 2278869 Clinical Trial.
-
Role of platelet inhibitor therapy in myocardial infarction.Cardiovasc Drugs Ther. 1989 Dec;3(6):797-813. doi: 10.1007/BF01869563. Cardiovasc Drugs Ther. 1989. PMID: 2487543 Review.
-
Influence of previous aspirin treatment and smoking on the electrocardiographic manifestations of injury in acute myocardial infarction.Heart. 2000 Jul;84(1):41-5. doi: 10.1136/heart.84.1.41. Heart. 2000. PMID: 10862586 Free PMC article.
-
Usefulness of peak systolic strain measurement by automated function imaging in the prediction of coronary perfusion in patients with acute myocardial infarction.Korean J Intern Med. 2010 Sep;25(3):260-8. doi: 10.3904/kjim.2010.25.3.260. Epub 2010 Aug 31. Korean J Intern Med. 2010. PMID: 20830222 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical